25 May 2013
Keywords: genzyme, starts, pivotal, antithrombin, iii, trials, transgenics
Article | 21 May 1998
Genzyme Transgenics has started three Phase III trials of recombinanthuman antithrombin III, representing the first time that a transgenically-produced protein ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.